TY  - CHAP
M1  - Book, Section
TI  - Vaginal Cancer
A1  - Boyd, Leslie
A1  - Muggia, Franco
A2  - Boyiadzis, Michael M.
A2  - Frame, James N.
A2  - Kohler, David R.
A2  - Fojo, Tito
Y1  - 2016
N1  - 
T2  - Hematology-Oncology Therapy, 2e
AB  - EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence:3,170  (Estimated  new  cases  for  2014  in  the  United  States)Incidence  of  clear  cell  adenocarcinoma  as  a  result  of  in  utero  diethylstilbestrol(DES)  exposure  estimated  at  1/1000Stage  at  presentationStage  I:28%Stage  II:43%Deaths:Estimated  880  in  2014Stage  III:16%Median  age:Squamous  cell  cancer  (60–65  years);  DES-related  adenocarcinoma/clear  cell  (19  years)Stage  IV:13%  Daling  JR  et  al.  Gynecol  Oncol  2002;84:263–270Siegel  R  et  al.  CA  Cancer  J  Clin  2014;64:9–29Tedeschi  C  et  al.  J  Low  Genit  Tract  Dis  2005;9:11–18  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - hemonc.mhmedical.com/content.aspx?aid=1159262643
ER  -